Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program.
Ja Young JeonSoo Jin LeeSieun LeeSoo Jin KimSeung Jin HanHae Jin KimDae-Jung KimYoung Seol KimJeong Taek WooKyu Jeung AhnMoonsuk NamSei Hyun BaikYongsoo ParkKwan-Woo LeePublished in: Journal of diabetes investigation (2018)
Metformin was associated with a lower failure risk than were sulfonylureas and meglitinides, but a comparable aGI failure rate.